Pharmaceuticals: Major
US companies operating in the same pharmaceuticals: major industry
The table below has US companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Pfizer, Inc.. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.33 T USD | 1,409.38 USD | −0.11% | 2.84 M | 0.97 | 46.30 | 30.44 USD | +50.54% | 0.47% | Health technology | Strong buy |
 JNJJohnson & Johnson | 640.75 B USD | 266.17 USD | −1.62% | 6.51 M | 0.92 | 40.38 | 6.59 USD | −36.38% | 1.95% | Health technology | Buy |
 ABBVAbbVie Inc. | 505.4 B USD | 286.00 USD | −0.98% | 5.37 M | 1.05 | 49.16 | 5.82 USD | +338.98% | 2.40% | Health technology | Buy |
 MRKMerck & Company, Inc. | 356.93 B USD | 144.67 USD | −2.49% | 8.89 M | 0.80 | 147.74 | 0.98 USD | −87.05% | 2.29% | Health technology | Buy |
 NVSNovartis AGDR | 293.96 B USD | 159.26 USD | −1.40% | 1.34 M | 0.55 | 30.42 | 5.24 USD | −28.61% | 1.91% | Health technology | Buy |
 AZNAstraZeneca PLC | 285.18 B USD | 183.88 USD | −1.45% | 3.89 M | 1.19 | 26.33 | 6.98 USD | +12.65% | 1.72% | Health technology | Buy |
 NVONovo Nordisk A/SDR | 178.83 B USD | 40.19 USD | −0.64% | 12.22 M | 1.26 | 9.82 | 4.09 USD | +12.75% | 3.04% | Health technology | Neutral |
 PFEPfizer, Inc. | 170.99 B USD | 30.00 USD | −2.18% | 53.06 M | 1.64 | 43.13 | 0.70 USD | −59.46% | 5.61% | Health technology | Neutral |
 VRTXVertex Pharmaceuticals Incorporated | 134.53 B USD | 530.76 USD | −4.05% | 2.37 M | 1.44 | 34.14 | 15.54 USD | +9.56% | 0.00% | Health technology | Buy |
 BMYBristol-Myers Squibb Company | 126.14 B USD | 61.71 USD | −2.08% | 10.29 M | 0.96 | 13.67 | 4.51 USD | +52.39% | 4.00% | Health technology | Buy |
 SNYSanofiDR | 108.19 B USD | 45.33 USD | −0.48% | 5.63 M | 1.18 | 23.35 | 1.94 USD | −30.91% | 3.87% | Health technology | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 100.68 B USD | 973.36 USD | +1.26% | 1.2 M | 1.25 | 21.49 | 45.30 USD | +8.44% | 0.38% | Health technology | Buy |
 GSKGSK plcDR | 98.06 B USD | 48.70 USD | −0.88% | 3.11 M | 0.67 | 16.98 | 2.87 USD | −18.18% | 3.63% | Health technology | Buy |
 TAKTakeda Pharmaceutical Company LimitedDR | 67.15 B USD | 20.75 USD | −0.57% | 2.58 M | 0.86 | 337.40 | 0.06 USD | −21.86% | 2.78% | Health technology | Buy |
 ONCBeOne Medicines Ltd.DR | 41.31 B USD | 355.00 USD | −1.74% | 475.2 K | 1.28 | 62.39 | 5.69 USD | — | 0.00% | Health technology | Strong buy |
 RPRXRoyalty Pharma plc | 38.27 B USD | 66.40 USD | −0.18% | 3.18 M | 1.02 | 35.35 | 1.88 USD | −18.22% | 1.39% | Health technology | Buy |
 HLNHaleon plcDR | 38.09 B USD | 8.84 USD | +0.91% | 31.98 M | 1.34 | 18.18 | 0.49 USD | +12.39% | 2.14% | Health technology | Buy |
 BIIBBiogen Inc. | 36.8 B USD | 248.93 USD | −0.03% | 1.06 M | 0.75 | 106.57 | 2.34 USD | −78.70% | 0.00% | Health technology | Buy |
 ZTSZoetis Inc. | 34.29 B USD | 82.99 USD | −0.23% | 3.73 M | 1.06 | 13.65 | 6.08 USD | +4.59% | 2.55% | Health technology | Neutral |
 ROIVRoivant Sciences Ltd. | 26.03 B USD | 36.04 USD | +0.42% | 6.69 M | 0.85 | — | −0.44 USD | +37.24% | 0.00% | Health technology | Strong buy |
 INCYIncyte Corporation | 23.97 B USD | 117.59 USD | −2.04% | 2.17 M | 1.06 | 62.57 | 1.88 USD | −68.47% | 0.00% | Health technology | Buy |
 INSMInsmed Incorporated | 22.91 B USD | 104.44 USD | −4.46% | 6.22 M | 1.41 | — | −2.82 USD | +54.44% | 0.00% | Health technology | Strong buy |
 VTRSViatris Inc. | 21.73 B USD | 18.92 USD | +1.34% | 7.55 M | 0.90 | — | −0.36 USD | +87.72% | 2.57% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 21.42 B USD | 159.89 USD | +1.20% | 3.79 M | 1.10 | 8.08 | 19.80 USD | +8,135.77% | 0.00% | Health technology | Buy |
 EXELExelixis, Inc. | 17.64 B USD | 72.31 USD | +3.11% | 3.85 M | 1.50 | 21.64 | 3.34 USD | +40.68% | 0.00% | Health technology | Buy |
 ASNDAscendis Pharma A/S | 15.6 B USD | 250.17 USD | +0.48% | 618.64 K | 1.16 | 19.06 | 13.12 USD | — | 0.00% | Health technology | Strong buy |
 JAZZJazz Pharmaceuticals plc | 14.91 B USD | 229.74 USD | +7.13% | 1.68 M | 2.07 | 77.93 | 2.95 USD | — | 0.00% | Health technology | Strong buy |
 RDYDr. Reddy's Laboratories LtdDR | 11.8 B USD | 14.30 USD | +1.20% | 2.66 M | 0.80 | 39.30 | 0.36 USD | −55.45% | 0.46% | Health technology | Buy |
 RGENRepligen Corporation | 11.4 B USD | 178.27 USD | +3.08% | 1.02 M | 0.65 | — | −0.21 USD | −915.18% | 0.00% | Health technology | Buy |
 TGTXTG Therapeutics, Inc. | 9.3 B USD | 60.75 USD | +1.33% | 2.15 M | 1.32 | 22.13 | 2.75 USD | +633.70% | 0.00% | Health technology | Strong buy |
 SYRESpyre Therapeutics, Inc. | 9.16 B USD | 99.27 USD | +3.94% | 904.9 K | 1.07 | — | −2.18 USD | +28.51% | 0.00% | Health technology | Strong buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 9.16 B USD | 396.32 USD | −8.08% | 1.98 M | 6.62 | — | −5.98 USD | +54.07% | 0.00% | Health technology | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 9.07 B USD | 140.24 USD | +0.62% | 674.72 K | 1.18 | 135.22 | 1.04 USD | +45.54% | 0.00% | Health technology | Strong buy |
 CORTCorcept Therapeutics Incorporated | 8.86 B USD | 81.93 USD | +1.83% | 1.52 M | 1.17 | 195.68 | 0.42 USD | −62.74% | 0.00% | Health technology | Buy |
 IBRXImmunityBio, Inc. | 8.79 B USD | 8.29 USD | +4.28% | 6.19 M | 0.63 | — | −0.97 USD | −96.55% | 0.00% | Health technology | Strong buy |
 CYTKCytokinetics, Incorporated | 8.66 B USD | 62.31 USD | +0.45% | 1.7 M | 1.35 | — | −7.22 USD | −41.03% | 0.00% | Health technology | Strong buy |
 PRAXPraxis Precision Medicines, Inc. | 7.83 B USD | 280.51 USD | +2.38% | 220.55 K | 0.51 | — | −12.94 USD | −5.32% | 0.00% | Health technology | Strong buy |
 ALKSAlkermes plc | 7.67 B USD | 45.69 USD | +1.78% | 2.33 M | 1.52 | 118.68 | 0.39 USD | −81.52% | 0.00% | Health technology | Buy |
 KNSAKiniksa Pharmaceuticals International, plc | 7.33 B USD | 93.29 USD | +2.74% | 1.02 M | 0.83 | 71.18 | 1.31 USD | +192.31% | 0.00% | Health technology | Strong buy |
 GRFSGrifols, S.A.DR | 7.32 B USD | 8.56 USD | +0.59% | 1 M | 1.34 | 11.05 | 0.77 USD | +61.67% | 1.01% | Health technology | Neutral |
 AMRXAmneal Pharmaceuticals, Inc. | 7.04 B USD | 20.21 USD | −1.13% | 6.44 M | 1.41 | 49.62 | 0.41 USD | +2,768.31% | 0.00% | Health technology | Strong buy |
 IONSIonis Pharmaceuticals, Inc. | 6.72 B USD | 40.42 USD | −1.99% | 4.01 M | 1.54 | — | −3.47 USD | −87.55% | 0.00% | Health technology | Strong buy |
 ORKAOruka Therapeutics, Inc. | 6.59 B USD | 99.55 USD | +4.32% | 822.16 K | 0.94 | — | −2.46 USD | +32.27% | 0.00% | Health technology | Strong buy |
 LGNDLigand Pharmaceuticals Incorporated | 6.27 B USD | 313.52 USD | +2.12% | 195.59 K | 0.75 | 139.85 | 2.24 USD | +7.91% | 0.00% | Health technology | Strong buy |
 BLTEBelite Bio, IncDR | 6.19 B USD | 152.17 USD | −0.98% | 149.88 K | 1.15 | — | −2.73 USD | −76.46% | 0.00% | Health technology | Strong buy |
 RYTMRhythm Pharmaceuticals, Inc. | 5.95 B USD | 86.44 USD | −7.49% | 7.11 M | 10.36 | — | −2.91 USD | +6.14% | 0.00% | Health technology | Strong buy |
 PTCTPTC Therapeutics, Inc. | 5.69 B USD | 68.12 USD | +11.89% | 2.64 M | 2.36 | — | −1.41 USD | −116.46% | 0.00% | Health technology | Buy |
 MIRMMirum Pharmaceuticals, Inc. | 5.65 B USD | 87.03 USD | +1.50% | 635.55 K | 1.09 | — | −14.55 USD | −1,101.55% | 0.00% | Health technology | Strong buy |
 MANEVeradermics, Incorporated | 5.58 B USD | 133.61 USD | +3.15% | 536.31 K | 0.91 | — | — | — | 0.00% | Health technology | Strong buy |
 ERASErasca, Inc. | 5.12 B USD | 14.64 USD | +4.20% | 3.8 M | 0.95 | — | −0.95 USD | −110.63% | 0.00% | Health technology | Strong buy |
 TVTXTravere Therapeutics, Inc. | 4.66 B USD | 49.41 USD | +0.30% | 9.08 M | 4.07 | — | −1.66 USD | −52.98% | 0.00% | Health technology | Strong buy |
 DFTXDefinium Therapeutics, Inc. | 4.49 B USD | 33.41 USD | +2.89% | 1.72 M | 0.92 | — | −3.44 USD | −134.91% | 0.00% | Health technology | Strong buy |
 LEGNLegend Biotech CorporationDR | 4.09 B USD | 21.48 USD | +1.80% | 1.64 M | 0.94 | — | −0.51 USD | +71.61% | 0.00% | Health technology | Buy |
 ARQTArcutis Biotherapeutics, Inc. | 4.02 B USD | 32.00 USD | +2.37% | 1.62 M | 0.78 | 154.51 | 0.21 USD | — | 0.00% | Health technology | Strong buy |
 LQDALiquidia Corporation | 3.78 B USD | 42.20 USD | +0.84% | 2.18 M | 0.68 | 30.93 | 1.36 USD | — | 0.00% | Health technology | Buy |
 XENEXenon Pharmaceuticals Inc. | 3.7 B USD | 38.23 USD | +1.62% | 1.25 M | 0.95 | — | −4.74 USD | −33.88% | 0.00% | Health technology | Strong buy |
 AMLXAmylyx Pharmaceuticals, Inc. | 3.66 B USD | 29.20 USD | +4.14% | 1.2 M | 0.98 | — | −1.43 USD | +42.67% | 0.00% | Health technology | Strong buy |
 OGNOrganon & Co. | 3.64 B USD | 13.85 USD | +0.22% | 3.66 M | 1.68 | 18.02 | 0.77 USD | −60.04% | 0.58% | Health technology | Neutral |
| PPBLSParabilis Medicines, Inc. | 3.61 B USD | 29.25 USD | +7.34% | 519.46 K | 0.42 | — | — | — | 0.00% | Health technology | Strong buy |
 TARSTarsus Pharmaceuticals, Inc. | 3.58 B USD | 72.64 USD | −0.93% | 755.78 K | 1.15 | — | −1.08 USD | +53.58% | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 3.54 B USD | 20.57 USD | +0.49% | 1.71 M | 1.22 | 9.26 | 2.22 USD | +66.85% | 0.00% | Health technology | Buy |
 VKTXViking Therapeutics, Inc. | 3.33 B USD | 26.09 USD | −2.76% | 2.74 M | 0.63 | — | −5.41 USD | −155.21% | 0.00% | Health technology | Strong buy |
 SUPNSupernus Pharmaceuticals, Inc. | 3.32 B USD | 28.15 USD | −32.85% | 2 | 0.00 | 7.79 | 3.61 USD | +259.69% | 0.00% | Health technology | Strong buy |
 RGCRegencell Bioscience Holdings Limited | 3.05 B USD | 6.15 USD | −2.23% | 94.91 K | 0.35 | — | −0.02 USD | −227.78% | 0.00% | Health technology | No rating |
 IDYAIDEAYA Biosciences, Inc. | 3.02 B USD | 31.33 USD | −0.98% | 1.89 M | 1.93 | — | −4.49 USD | −142.22% | 0.00% | Health technology | Strong buy |
 VRDNViridian Therapeutics, Inc. | 2.85 B USD | 25.15 USD | −0.59% | 4.06 M | 2.10 | — | −3.71 USD | +13.06% | 0.00% | Health technology | Strong buy |
 NAMSNewAmsterdam Pharma Company N.V. | 2.38 B USD | 19.90 USD | +1.74% | 2.07 M | 1.34 | — | −2.18 USD | −35.06% | 0.00% | Health technology | Strong buy |
 BHVNBiohaven Ltd. | 2.36 B USD | 15.61 USD | +2.97% | 2.02 M | 0.37 | — | −3.86 USD | +49.16% | 0.00% | Health technology | Buy |
 PBHPrestige Consumer Healthcare Inc. | 2.35 B USD | 49.54 USD | −0.38% | 610.52 K | 1.19 | 13.87 | 3.57 USD | −16.20% | 0.00% | Health technology | Buy |
 HCMHUTCHMED (China) LimitedDR | 2.3 B USD | 13.08 USD | −1.43% | 28.85 K | 0.73 | 128.61 | 0.10 USD | −96.21% | 0.00% | Health technology | Strong buy |
 PRGOPerrigo Company plc | 2.18 B USD | 15.70 USD | −0.32% | 2.15 M | 1.04 | — | −12.51 USD | −2,139.20% | 7.37% | Health technology | Neutral |
 HRMYHarmony Biosciences Holdings, Inc. | 2.16 B USD | 37.02 USD | −2.35% | 1.45 M | 1.17 | 12.00 | 3.09 USD | −0.53% | 0.00% | Health technology | Buy |
 ZYMEZymeworks Inc. | 2.14 B USD | 30.13 USD | +3.93% | 2.52 M | 1.80 | — | −2.01 USD | −105.50% | 0.00% | Health technology | Strong buy |
 VCELVericel Corporation | 2.1 B USD | 41.09 USD | +1.43% | 635.18 K | 1.11 | 88.90 | 0.46 USD | +270.65% | 0.00% | Health technology | Strong buy |
 SRPTSarepta Therapeutics, Inc. | 1.96 B USD | 18.54 USD | +1.20% | 1.4 M | 0.85 | — | −2.90 USD | −281.95% | 0.00% | Health technology | Neutral |
| BBRVEBraveheart Bio, Inc. | 1.93 B USD | 21.39 USD | +1.66% | 305.54 K | 1.26 | — | — | — | 0.00% | Health technology | Strong buy |
 AGIOAgios Pharmaceuticals, Inc. | 1.86 B USD | 31.20 USD | +4.17% | 684.86 K | 0.52 | — | −7.01 USD | −163.46% | 0.00% | Health technology | Buy |
 MAZEMaze Therapeutics, Inc. | 1.79 B USD | 32.25 USD | +6.19% | 488.82 K | 0.74 | — | −2.53 USD | −50.45% | 0.00% | Health technology | Strong buy |
 SLSSELLAS Life Sciences Group, Inc. | 1.79 B USD | 8.87 USD | +3.74% | 5.05 M | 0.57 | — | −0.21 USD | +35.38% | 0.00% | Health technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 1.64 B USD | 16.63 USD | +2.02% | 3.71 M | 1.20 | — | −5.84 USD | −5.66% | 0.00% | Health technology | Buy |
 PAHCPhibro Animal Health Corporation | 1.53 B USD | 37.65 USD | −2.81% | 289.49 K | 1.76 | 15.47 | 2.43 USD | +105.22% | 1.24% | Health technology | Buy |
 INVAInnoviva, Inc. | 1.51 B USD | 20.93 USD | −0.43% | 712.65 K | 1.10 | 5.10 | 4.10 USD | +1,137.16% | 0.00% | Health technology | Buy |
 OCULOcular Therapeutix, Inc. | 1.5 B USD | 6.82 USD | +1.34% | 2 M | 0.89 | — | −1.41 USD | −10.60% | 0.00% | Health technology | Strong buy |
 GPCRStructure Therapeutics Inc.DR | 1.46 B USD | 20.35 USD | −0.59% | 612.88 K | 0.72 | — | −3.08 USD | +1.47% | 0.00% | Health technology | Strong buy |
 ETONEton Pharmaceuticals, Inc. | 1.46 B USD | 50.95 USD | +0.28% | 340.6 K | 0.90 | 134.72 | 0.38 USD | — | 0.00% | Health technology | Strong buy |
 PCRXPacira BioSciences, Inc. | 1.45 B USD | 36.39 USD | −0.03% | 1.08 M | 1.29 | 104.87 | 0.35 USD | — | 0.00% | Health technology | Neutral |
 NBTXNanobiotix S.A.DR | 1.44 B USD | 28.56 USD | +1.60% | 167.79 K | 1.24 | — | −1.27 USD | −58.83% | 0.00% | Health technology | Strong buy |
 GHRSGH Research PLC | 1.39 B USD | 20.28 USD | −1.07% | 476.16 K | 1.29 | — | −0.99 USD | −33.76% | 0.00% | Health technology | Strong buy |
 DMRADamora Therapeutics, Inc. | 1.36 B USD | 22.08 USD | +2.22% | 473.17 K | 1.11 | — | −124.78 USD | −850.33% | 0.00% | Health technology | Strong buy |
 OMEROmeros Corporation | 1.32 B USD | 18.27 USD | +2.47% | 887.38 K | 0.84 | 12.71 | 1.44 USD | — | 0.00% | Health technology | Buy |
 LBRXLB Pharmaceuticals Inc | 1.3 B USD | 40.33 USD | +3.30% | 245.84 K | 0.80 | — | −2.98 USD | −132.05% | 0.00% | Health technology | Strong buy |
 NKTRNektar Therapeutics | 1.29 B USD | 37.76 USD | +2.19% | 429.01 K | 0.65 | — | −6.70 USD | +23.18% | 0.00% | Health technology | Buy |
 AAPGAscentage Pharma Group International - American Depository SharesDR | 1.27 B USD | 13.48 USD | −0.59% | 1.82 K | 0.21 | — | −2.26 USD | −12.46% | 0.00% | Health technology | Strong buy |
 MNKDMannKind Corporation | 1.2 B USD | 3.73 USD | +2.19% | 4.87 M | 1.85 | — | −0.14 USD | −229.64% | 0.00% | Health technology | Strong buy |
 AVLNAvalyn Pharma Inc. | 1.19 B USD | 26.81 USD | +4.73% | 450.18 K | 0.92 | — | — | — | 0.00% | Health technology | Strong buy |
 AMPHAmphastar Pharmaceuticals, Inc. | 1.15 B USD | 27.12 USD | +0.33% | 550.21 K | 1.37 | 15.89 | 1.71 USD | −36.12% | 0.00% | Health technology | Neutral |
 SPTXSeaport Therapeutics, Inc. | 1.08 B USD | 20.20 USD | +0.95% | 393.65 K | 1.50 | — | — | — | 0.00% | Health technology | Strong buy |
 HROWHarrow, Inc. | 1.07 B USD | 28.54 USD | +1.21% | 625.37 K | 1.20 | — | −1.00 USD | −236.87% | 0.00% | Health technology | Strong buy |
 IMTXImmatics N.V. | 1.06 B USD | 7.08 USD | +0.21% | 1.32 M | 1.06 | — | −1.85 USD | −164.71% | 0.00% | Health technology | Strong buy |
 CGEMCullinan Therapeutics, Inc. | 1.01 B USD | 15.75 USD | +5.49% | 788.71 K | 1.47 | — | −3.39 USD | +3.56% | 0.00% | Health technology | Strong buy |